Your browser doesn't support javascript.
loading
A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer.
Wang, An-Jin; Gao, Yang; Shi, Yu-Ying; Dai, Meng-Yuan; Cai, Hong-Bing.
Affiliation
  • Wang AJ; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Gao Y; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, Hubei, China.
  • Shi YY; Hubei Cancer Clinical Study Center, Wuhan, Hubei, China.
  • Dai MY; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Cai HB; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, Hubei, China.
Front Pharmacol ; 13: 1093666, 2022.
Article in En | MEDLINE | ID: mdl-36618922
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland